Novartis Airs Mea Culpa As 2nd Circ. Probes Kickback Theory

After a series of startling kickback cases, Novartis Pharmaceuticals on Wednesday contrasted its past misdeeds with newer accusations it bribed prescribers, and Second Circuit judges seemed sympathetic as they pressured a...

Already a subscriber? Click here to view full article